This Amendment No. 1 to
Schedule 13D is jointly filed by and on behalf of each reporting person to
amend the Schedule 13D relating to the common stock of the issuer filed
November 21, 2007 by such person with the Commission. This Amendment No. 1 to Schedule 13D is filed
to disclose a material decrease in the percentage of the common stock that may
be deemed to be beneficially owned by each reporting person. Each capitalized term used and not defined
herein shall have the meaning assigned to such term in the Schedule 13D. Except as otherwise provided herein, each
Item of the Schedule 13D remains unchanged.
Item 1.
|
Security and Issuer
|
|
Unchanged.
|
|
|
Item 2.
|
Identity and Background
|
|
Item 2 of the Schedule 13D is hereby amended and
restated in its entirety as follows:
|
Reporting Persons: Versata Enterprises, Inc.; Trilogy,
Inc.; and Joseph A. Liemandt
The name of each person filing this statement and the
place of organization or citizenship of such person is stated in Items 1 and 6
on the cover page(s) hereto. The
principal business of Versata Enterprises, Inc. is providing enterprise
software products and services. Versata
is a wholly owned subsidiary of Trilogy, Inc.
Trilogy may be deemed to control Versata and beneficially own securities
owned by Versata. The principal business
of Trilogy is providing technology-powered business services. Joseph A. Liemandt is an officer and a
director of Versata and the President, Chief Executive Officer, and Chairman of
the board of directors of Trilogy and may be deemed to control each of Versata
and Trilogy. Mr. Liemandt may be deemed
to beneficially own securities owned by each of Versata and Trilogy. Each of Mr. Liemandt and Diane
Liemandt-Reimann, a director of Trilogy and the mother of Mr. Liemandt, own
limited partnership interests in a limited partnership that may be deemed to be
controlled by Charles I. Frumberg, a director of Trilogy. The present principal occupation of Mr.
Liemandt is serving as the President, Chief Executive Officer, and Chairman of
the board of directors of Trilogy. The
address of the principal office or business address of each reporting person is
6011 West Courtyard Dr., Suite 300, Austin, Texas 78730.
During the last five years, no reporting person has been convicted in a
criminal proceeding, or was a party to a civil proceeding, required to be
disclosed herein.
Other Persons
Charles I. Frumberg, a director of Trilogy, is the
managing member of the investment manager of
Emancipation Capital Master, Ltd. (Emancipation Capital). According to information furnished by
Emancipation Capital and Mr. Frumberg, each of Emancipation Capital and Mr.
Frumberg may be deemed to (i) share power to vote or to direct the vote as to,
(ii) share power to dispose or to direct the disposition of, and (iii)
beneficially own, in each case, 456,449 shares (or 4.8%) of the common stock of
the issuer. Emancipation Capital and Mr.
Frumberg disclaim beneficial ownership of securities owned by the reporting
persons and disclaim membership in a group with the reporting persons.
The information with respect to Emancipation Capital
and Mr. Frumberg is disclosed herein because Instruction C of Schedule 13D
requires information to be given with respect to each director of Trilogy. If any reporting person is deemed to be a
member of a group with Emancipation Capital or Mr. Frumberg with respect to the
issuer or securities of the issuer, each reporting person may be deemed to (i)
share power to vote or to direct the vote as to, (ii) share power to dispose or
to direct the disposition of, and (iii) beneficially own, in each case, 700,769
shares (or 7.3%) of the common stock of the issuer. However, each reporting person disclaims
beneficial ownership of securities owned by Emancipation Capital or Mr. Frumberg
and disclaims membership in a group with Emancipation Capital or Mr.
Frumberg.
In determining information with respect to
Emancipation Capital and Mr. Frumberg, each reporting person has relied upon
information set forth in filings with the Commission by Emancipation Capital
and Mr. Frumberg or other information which such reporting person knows or has
reason to know. No reporting person
knows or has reason to believe that the information herein concerning any other
person is inaccurate or is responsible for the completeness or accuracy of such
information.
5
The information, if any, called for by Items 2-6,
inclusive, of Schedule 13D with respect to any person enumerated in Instruction
C of Schedule 13D and required to be included in this statement is included in
Exhibit 99.1 hereto or otherwise herein.
The information contained in Exhibit 99.1 hereto and each other Item
herein is incorporated by reference in answer or partial answer to this Item.
Item 3.
|
Source and Amount of Funds or Other Consideration
|
|
Unchanged.
|
|
|
Item 4.
|
Purpose of Transaction
|
|
Unchanged.
|
|
|
Item 5.
|
Interest in Securities of the Issuer
|
|
Item 5(c) of the Schedule 13D is hereby amended and
restated in its entirety as follows:
|
(c) Transactions
in the class of securities reported on that were effected during the past sixty
days or since the most recent filing of Schedule 13D, whichever is less, by the
reporting persons are described below.
Transaction
Date
|
|
Effecting
Person(s)
|
|
Shares
Acquired
|
|
Shares
Disposed
|
|
Price
Per Share
|
|
Description
of Transaction
|
|
December 12, 2007
|
|
Versata Enterprises, Inc.
|
|
0
|
|
400
|
|
$
|
6.70
|
(1)
|
Open
market sale
|
|
December 14, 2007
|
|
Versata Enterprises, Inc.
|
|
0
|
|
3,888
|
|
$
|
6.60
|
(1)
|
Open
market sale
|
|
December 17, 2007
|
|
Versata Enterprises, Inc.
|
|
0
|
|
1,392
|
|
$
|
6.60
|
(1)
|
Open
market sale
|
|
(1) Excludes
commission of $0.05 per share.
Except as otherwise described herein, no transactions
in the common stock of the issuer were effected during the past sixty days or
since the most recent filing of Schedule 13D, whichever is less, by any
reporting person.
Item 5(e) of the Schedule 13D is hereby amended and
restated in its entirety as follows:
Each reporting person ceased to be the beneficial
owner of more than five percent of the common stock of the issuer on December
12, 2007.
Item 6.
|
Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of the Issuer
|
|
Unchanged.
|
|
|
Item 7.
|
Material to Be Filed as Exhibits
|
|
The
following exhibits are filed as exhibits hereto:
|
Exhibit
|
|
Description of Exhibit
|
|
|
|
24.1
|
|
Joint Filing Agreement and Power of Attorney
(incorporated herein by reference from Exhibit 24.1 to the Schedule 13D
relating to the common stock of the issuer filed November 21, 2007 by the
reporting person with the Commission)
|
|
|
|
99.1
|
|
Additional Information (incorporated herein by
reference from Exhibit 99.1 to the Schedule 13D relating to the common stock
of the issuer filed November 21, 2007 by the reporting person with the
Commission)
|
6